James Loerop - Jul 8, 2021 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: EVP Business Development
Signature: /s/ James Loerop
Stock symbol: ANIK
Transactions as of: Jul 8, 2021
Transactions value $: -$31,608
Form type: 4
Date filed: 7/12/2021, 04:15 PM
Next filing: Feb 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Options Exercise	$0	+3K	+90.28%	$0.00	6.32K	Jul 8, 2021	Direct	F1
transaction	ANIK	Common Stock	Tax liability	-$31.6K	-731	-11.56%	$43.24	5.59K	Jul 8, 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIK	Restricted Stock Unit	Options Exercise	$0	+3K		$0.00	3K	Jul 8, 2021	Common Stock	3K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects the second vesting installment of RSUs granted on July 8, 2019.
F2	Reflects an aggregate of 731 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on July 8, 2021.
F3	Reflects the closing price of ANIK common stock on July 8, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.